-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Vir Biotechnology, Maintains $15 Price Target

Benzinga·12/30/2025 13:33:05
Listen to the news
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Vir Biotechnology (NASDAQ:VIR) with a Buy and maintains $15 price target.